ADMA Biologics Analyst Price Targets

ADMA Biologics Inc

ADMANASDAQ

$9.28

-0.10-1.07%

最終更新: Sep 28, 7:01 AM

Wall Street analyst price targets and consensus rating for ADMA Biologics (ADMA).

Price Target Range — 9 Quarters

Analyst Consensus — 5 Analysts

1S.Buy

3Buy

1Hold

Consensus RatingBuy# Analysts5Avg. Consensus PT$23Upside to Avg. PT+150.5%

Rating Trend — Last 9 Months

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 15, 2026	Mizuho	Anthony Petrone	PT Cut	Outperform	$20→$17
May 7, 2026	Canaccord Genuity	Gary Nachman	PT Cut	Buy	$21→$18
May 7, 2026	Mizuho	Anthony Petrone	PT Cut	Outperform	$24→$20
Apr 21, 2026	Canaccord Genuity	Gary Nachman	Initiate	Buy	$21
Apr 13, 2026	Mizuho	Anthony Petrone	PT Cut	Outperform	$30→$24
Mar 26, 2026	Cantor Fitzgerald	Kristen Kluska	Downgrade	Overweight→Neutral	—
May 8, 2025	Raymond James	Elliot Wilbur	PT Raise	Strong Buy	$25→$32
Mar 4, 2025	Cantor Fitzgerald	Kristen Kluska	Maintained	Overweight	$25
Nov 8, 2024	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$18→$26
Nov 8, 2024	Raymond James	Elliot Wilbur	PT Raise	Strong Buy	$18→$25
Oct 14, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$18
Sep 20, 2024	Cantor Fitzgerald	Kristen Kluska	Maintained	Overweight	$20
Aug 12, 2024	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$10→$18
Aug 9, 2024	Cantor Fitzgerald	Kristen Kluska	PT Raise	Overweight	$15→$20
Jul 9, 2024	Cantor Fitzgerald	Kristen Kluska	PT Raise	Overweight	$10→$15
Jun 20, 2024	Mizuho	Anthony Petrone	PT Raise	Buy	$12→$14
May 10, 2024	Raymond James	Elliot Wilbur	PT Raise	Strong Buy	$8→$10
May 10, 2024	Cantor Fitzgerald	Kristen Kluska	PT Raise	Overweight	$8→$10
May 10, 2024	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$8→$10
May 10, 2024	Mizuho	Anthony Petrone	PT Raise	Buy	$10→$12